An integrative multi-omic analysis reveals a major metabolic rewiring between baby foreskin keratinocytes and adult female abdominal keratinocytes.
cell energy
metabolomic
skin barrier
skin development
transcriptomic
Journal
Experimental dermatology
ISSN: 1600-0625
Titre abrégé: Exp Dermatol
Pays: Denmark
ID NLM: 9301549
Informations de publication
Date de publication:
04 2022
04 2022
Historique:
revised:
26
10
2021
received:
21
07
2021
accepted:
14
11
2021
pubmed:
20
11
2021
medline:
9
4
2022
entrez:
19
11
2021
Statut:
ppublish
Résumé
Even though its development starts early in utero, neonatal skin is still immature at birth relative to adult and undergoes a maturation process extending to the first years of life. It is now established that the stratum corneum is thinner and dryer and that skin contains less natural moisturizing factors and lipids in newborns compared to children and adults. Moreover, it has been shown that skin surface area expansion is not linear throughout life and is peaking perinatally, suggesting that baby skin has a higher epidermal cellular turnover. Despite growing resources showing differences between adult and infant skin physiology, molecular and metabolic specificities of baby skin are still poorly understood. To address this critical knowledge gap, we performed an integrative transcriptomic and metabolomic study comparing human primary foreskin and abdominal keratinocytes from male babies and female adults, respectively. Based on state-of-the-art integrative frameworks, our analyses revealed a major shift in the global energetic metabolism in baby foreskin keratinocytes compared to adult abdominal keratinocytes, highlighting increased amino acid metabolism and mitochondrial oxidative phosphorylation in baby cells to fuel the citric acid cycle, while showing glycolysis as the major cell energy source in adult cells.
Identifiants
pubmed: 34796552
doi: 10.1111/exd.14503
pmc: PMC9299729
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
622-627Informations de copyright
© 2021 Johnson and Johnson Santé Beauté France. Experimental Dermatology published by John Wiley & Sons Ltd.
Références
Exp Dermatol. 2022 Apr;31(4):622-627
pubmed: 34796552
J Invest Dermatol. 2012 Aug;132(8):1951-3
pubmed: 22797297
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
Acta Derm Venereol. 2003;83(6):410-3
pubmed: 14690333
Int J Cosmet Sci. 2011 Feb;33(1):17-24
pubmed: 20807257
Science. 2019 Jul 19;365(6450):
pubmed: 31320509
Trends Mol Med. 2020 Nov;26(11):975-986
pubmed: 32371170
J Invest Dermatol. 2012 Sep;132(9):2131-3
pubmed: 22895445
Biosci Rep. 1985 May;5(5):393-400
pubmed: 3896338
Nat Commun. 2020 Aug 25;11(1):4239
pubmed: 32843640
FASEB J. 2003 Sep;17(12):1706-8
pubmed: 12958183
J Dermatol Sci. 2008 Mar;49(3):187-94
pubmed: 17624739
EMBO Rep. 2014 Dec;15(12):1243-53
pubmed: 25381661
Sci Signal. 2013 Feb 05;6(261):ra8
pubmed: 23386745
Nucleic Acids Res. 2009 Jul;37(Web Server issue):W652-60
pubmed: 19429898
Science. 2021 Jan 22;371(6527):
pubmed: 33479125
Skin Pharmacol Physiol. 2012;25(1):25-33
pubmed: 21912200
Biochim Biophys Acta. 2014 Mar;1841(3):280-94
pubmed: 24262790
Curr Opin Plant Biol. 2004 Jun;7(3):254-61
pubmed: 15134745
Genes Dev. 2006 Nov 15;20(22):3185-97
pubmed: 17114587
Acta Naturae. 2013 Oct;5(4):22-33
pubmed: 24455180